UNITAID

Oxfam today welcomed an agreement between the UNITAID-backed Medicine Patent Pool Foundation (MPPF) and the US National Institutes of Health (NIH) to license the antiretroviral drug darunavir to the patent pool. The pool was set up to reduce the cost of HIV medicines.

Access to medicines is a major challenge for people in developing countries. With the right medicines, diseases such as HIV and AIDS, tuberculosis (TB), and malaria are treatable.